News - Generics

Filter

Current filters:

Generics

Popular Filters

1140 to 1164 of 1239 results

Australian PBS deferrals risk creating two-tier health system, drugmakers argue

25-07-2011

Federal Cabinet’s decision to defer the listing of new medicines on the Pharmaceutical Benefits…

Asia-PacificGenericsHealthcarePharmaceuticalPoliticsPricing

Russia’n firm Grumant invests $45 million in herbal APIs plant

25-07-2011

Grumant, one of Russia’s largest manufacturers of pharmaceutical ingredients based on medicinal…

EuropeFinancialGenericsGrumantMarkets & Marketing

US Senate Judiciary Committee passes legislation to stop pay-for-delay patent settlements

25-07-2011

US legislation to stop anticompetitive drug patent settlements, the bipartisan Bill S 27, Preserve Access…

GenericsLegalNorth AmericaPatentsPharmaceutical

Dr Reddy’s acquires Rx business in Russia and other CIS markets; reports 1st-qtr FY 2012 results

25-07-2011

Generics company Dr Reddy’s Laboratories (NYSE: RDY), India’s second largest drugmaker, has…

Dr Reddy's LaboratoriesFinancialGenericsMergers & Acquisitions

US generics market poised for “stupendous” growth, says RNCOS

23-07-2011

Backed by factors like patent expiration of drugs and aging population, the US generics market will expand…

DiabetesGenericsMarkets & MarketingNeurologicalNorth AmericaPatents

Merck & Co sets up China marketing JV with Simcere

22-07-2011

US pharma giant Merck & Co (NYSE: MRK) has signed a framework agreement with leading Chinese drugmaker…

Asia-PacificCardio-vascularDiabetesGenericsMarkets & MarketingMerck & CoPharmaceuticalSimcere Pharmaceutical

Zydus Cadila 1st-qtr fiscal net profit jumps 15%

20-07-2011

Indian drugmaker Zydus Cadila reported sales of 11.89 billion rupees ($175.2 million) for its fiscal…

FinancialGenericsZydus Cadila

Major changes at US FDA, with new posts and appointments

19-07-2011

The world of FDA regulation is changing rapidly and, in an effort to keep current, US Food and Drug Administration…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

US Senators debut bipartisan bill to encourage states to use generic drugs In Medicaid program

18-07-2011

In an effort to increase consumer flexibility and save taxpayer dollars, US Senators Scott Brown (Republican,…

GenericsHealthcareNorth AmericaPharmaceuticalPolitics

Par Pharma branded business faces setback, say Zacks analysts

17-07-2011

US drugmaker Par Pharmaceuticals’ (NYSE: PRX) proprietary products division, Strativa Pharmaceuticals,…

FinancialGenericsOncologyPar PharmaceuticalsPharmaceuticalStrativa PharmaceuticalsZuplenz

API production in Russia: scarce but slowly developing

14-07-2011

Over the past few years a trend toward slow development has been observed on the part of producers of…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Japan and China dominate Asian API market

14-07-2011

The market for active pharmaceutical ingredients (APIs) is highest in the USA, followed by Europe and…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

US generics market, worth $74 billion in 2009, set to grow at 10% CAGR

14-07-2011

The US generics market has shown a solid growth during the past few years backed by factors, such as…

Gastro-intestinalsGenericsMarkets & MarketingNorth America

Sandoz expands strategic alliance with Nipro in Japan; Shionogi licenses drug to Ildong

14-07-2011

Sandoz, a generics subsidiary of US drug major Novartis (NOVN: VX) has entered into a strategic alliance…

Asia-PacificGenericsIldong PharmaLicensingNovartisPharmaceuticalpirfenidoneSandozShionogi

First meeting of BRICS health ministers brings new leadership to global health

13-07-2011

Universal access to medicines was a key topic of discussion at a meeting this week of health ministers…

GenericsGlobalHealthcarePatentsPolitics

Hikma takes stake in China’s Hubei Haosun to enhance API sourcing

11-07-2011

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has acquired…

GenericsHikma PharmaceuticalsHubei HaosunMergers & AcquisitionsOncology

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched

11-07-2011

US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…

BayerCardio-vascularEuropeGenericsLipitorPatentsPfizerPharmaceuticalReproductiveYasmin

New date set for hearing of the Kenya Anti-Counterfeit court case

10-07-2011

Hearings of the constitutional case challenging the implementation of the Kenya Anti-Counterfeit Act,…

GenericsLegalRest of the World

Government tenders for production of life-saving drugs in Russia

08-07-2011

The Russian Ministry of Industry and Trade Ministry has announced a tender for the production of five…

GenericsMarkets & Marketing

Generic drugs changing the economics of treating chronically ill patients, US study finds

07-07-2011

As the USA seeks to expand health care coverage to more citizens without adding burdensome costs, researchers…

GenericsHealthcareNorth AmericaPricing

Decrease in problematic pay-for-delay patent settlements in the EU, says Commission

07-07-2011

The European Commission's second monitoring exercise of patent settlements in the pharmaceutical sector…

EuropeGenericsLegalPatentsPharmaceutical

Shire sues Sandoz and Amneal for Vyvanse patent infringements

05-07-2011

Ireland-headquartered drugmaker Shire (LSE: SHP) says it has filed law suits in the US District Court…

Amneal PharmaGenericsLegalNeurologicalNorth AmericaNovartisPatentsPharmaceuticalSandozShireVyvanse

1140 to 1164 of 1239 results

Back to top